Safety,Efficacy & Tolerability of Arikace™ in Cystic Fibrosis Patients

• Research type

  Research Study

• Full title

  Randomised, Active-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Arikace™ in Cystic Fibrosis Patients with Chronic Infection due to Pseudomonas Aeruginosa (Pa)

• IRAS ID

  76741

• Contact name

  Diana Bilton

• Contact email

  d.bilton@rbht.nhs.uk

• Sponsor organisation

  Insmed Incorporated

• Eudract number

  2011-000441-20

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  NCT01315678

• Research summary

  exceeds word count

• REC name

  Wales REC 3

• REC reference

  11/WA/0156

• Date of REC Opinion

  3 Aug 2011

• REC opinion

  Further Information Favourable Opinion